Basal cell carcinoma: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 40: | Line 40: | ||
== Diagnosis == | == Diagnosis == | ||
[[Basal cell carcinoma history and symptoms| History and Symptoms]] | [[Basal cell carcinoma physical examination | Physical Examination]] | [[Basal cell carcinoma staging | Staging]] | [[Basal cell carcinoma laboratory tests | | [[Basal cell carcinoma history and symptoms| History and Symptoms]] | [[Basal cell carcinoma physical examination | Physical Examination]] | [[Basal cell carcinoma staging | Staging]] | [[Basal cell carcinoma laboratory tests |Laboratory Findings]] | [[Basal cell carcinoma other diagnostic studies|Other Diagnostic Studies]] | ||
==[[Basal cell carcinoma treatment|Treatment]]== | ==[[Basal cell carcinoma treatment|Treatment]]== |
Revision as of 16:00, 21 August 2012
Basal cell carcinoma | |
Basal cell carcinoma | |
ICD-9 | 173 |
ICD-O: | 8090/3-8093/3 |
OMIM | 605462 |
DiseasesDB | 1264 |
MeSH | D002280 |
Basal cell carcinoma Microchapters |
Diagnosis |
---|
Case Studies |
Basal cell carcinoma On the Web |
American Roentgen Ray Society Images of Basal cell carcinoma |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Basal cell carcinoma from other Disorders
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Staging | Laboratory Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies